Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advances in understanding genomic markers and pharmacogenetics of Parkinson's disease.

Expert opinion on drug metabolism & toxicology - 1 Jan 2016

Jiménez-Jiménez Félix Javier, Alonso-Navarro Hortensia, García-Martín Elena, Agúndez José A G

Abstract excerpt

INTRODUCTION: The inheritance pattern of Parkinson's disease (PD) is likely multifactorial (owing to the interplay of genetic predisposition and environmental factors). Many pharmacogenetic studies have tried to establish a possible role of candidate genes in PD risk. Several studies have focused on the influence of genes in the response to antiparkinsonian drugs and in the risk of developing side-effects of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiparkinson Agents
Share to Genetic Association Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genome, Human

Share to Genomics

Share to Parkinson Disease

Share to Pharmacogenetics

Share to Risk Factors

Source

Identifiers

PMID: 26910127
DOI: 10.1517/17425255.2016.1158250

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advances in understanding genomic markers and pharmacogenetics of Parkinson's disease.PMID 26910127Read ↗

Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?Semantic proximity Read ↗

Genetics of Parkinson’s Disease - A Clinical PerspectiveSemantic proximity Read ↗

Genetic risk factors in Parkinson's disease.Semantic proximity Read ↗

[Genetic risk variants in Parkinson's disease and other movement disorders].Semantic proximity Read ↗

Genetic factors involved in the pathogenesis of Parkinson's diseaseSemantic proximity Read ↗

Pharmacogenetics of antiparkinsonian drug treatment: a systematic review.Semantic proximity Read ↗

Genetic susceptibility in Parkinson's disease.Semantic proximity Read ↗

Epidemiology, environmental risk factors and genetics of Parkinson's disease.Semantic proximity Read ↗

The genetics of Parkinson's disease.Semantic proximity Read ↗

An update on the monogenic causes of Parkinson's disease: Impact on patient stratification and personalised medicine.Semantic proximity Read ↗

Genetic risk factors in Parkinson's disease: single gene effects and interactions of genotypes.Semantic proximity Read ↗

Molecular genetic pathways in Parkinson's disease: a review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.